Tvardi Therapeutics, Inc. (TVRD)
(Delayed Data from NSDQ)
$7.00 USD
+0.31 (4.63%)
Updated Oct 14, 2025 04:00 PM ET
After-Market: $6.81 -0.19 (-2.71%) 7:50 PM ET
3-Hold of 5 3
F Value A Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Tvardi Therapeutics, Inc. has a market cap of $62.74M, which represents its share price of $6.69 multiplied by its outstanding shares number of 9.38M. As a small-cap company, TVRD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TVRD 7.00 +0.31(4.63%)
Will TVRD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for TVRD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TVRD
TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals
TVRD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TVRD
Tivardi downgraded at Raymond James following TTI-101 trial failure
Tvardi Therapeutics (TVRD) Downgraded by Raymond James | TVRD Stock News
Is TVRD poised for gains? Slingshot Bullish shows up after crashing 83.92%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tvardi downgraded to Market Perform from Outperform at Raymond James